We use Google Analytics to see which pages are read and how the site is used, so we know what to improve. This only runs if you accept. See our privacy notice for details.

Dáil

Written answer

Medicinal Products

Summary

The Minister referred the Deputy’s query on annual cancer-medicine reimbursement approvals to the HSE, which has statutory responsibility for such decisions.

193. Deputy Marie Sherlock asked the Minister for Health the number of cancer medicines approved for reimbursement for each of the years from 2020 to 2025 and to date in 2026. [78272/26]

Comment on this

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Comment on this